Can I Take Vitamin B6 with Cytomel (Liothyronine)?

Why This Combination Comes Up

Patients on liothyronine (brand name Cytomel) often supplement with B vitamins to support energy metabolism, address fatigue, or fill nutritional gaps common in hypothyroidism. Vitamin B6 is one of the most popular standalone B-vitamin supplements in the United States, with an estimated 15.3% of U.S. Adults reporting B6 supplement use according to NHANES 2003-2004 data published in the Journal of Nutrition [1]. The concern typically centers on whether pyridoxine interferes with thyroid hormone action or absorption.

Where the Confusion Originates

Online interaction checkers sometimes flag B6 with thyroid medications broadly, but they are referencing absorption interactions specific to levothyroxine (T4) and minerals like calcium, iron, and aluminum. Liothyronine is a synthetic form of triiodothyronine (T3), which is absorbed rapidly in the jejunum [2]. Vitamin B6, a water-soluble vitamin, is absorbed primarily in the jejunum and ileum through passive diffusion at pharmacologic doses and does not form insoluble chelates with thyroid hormones the way divalent cations do [3].

What Interaction Databases Say

The Natural Medicines Comprehensive Database and Mayo Clinic drug interaction tools list no interaction between pyridoxine and liothyronine. The FDA-approved Cytomel prescribing information does not list vitamin B6 among substances that affect liothyronine pharmacokinetics [4]. This is consistent across multiple commercial interaction-checking platforms (Lexicomp, Micromedex, Clinical Pharmacology).

Pharmacokinetics: No Meaningful Overlap

Liothyronine is almost completely absorbed from the GI tract, reaching peak serum concentrations in 2 to 4 hours. It has a half-life of approximately 1 day and is metabolized primarily through sequential deiodination in the liver and kidneys [2]. Vitamin B6, once absorbed, is converted to its active coenzyme form, pyridoxal 5'-phosphate (PLP), primarily in the liver via pyridoxal kinase and pyridoxine 5'-phosphate oxidase [3].

Absorption and Metabolism Are Independent

These two substances use entirely different transport mechanisms. Liothyronine uptake involves monocarboxylate transporter 8 (MCT8) and organic anion transporting polypeptides (OATPs) at the cellular level [5]. B6 enters cells through facilitated diffusion and is phosphorylated intracellularly. There is no competitive binding, no shared CYP450 pathway, and no protein-binding displacement between them.

No Dose-Separation Window Needed

Because no chelation, pH-dependent solubility interaction, or transporter competition exists, there is no pharmacokinetic rationale for separating doses. You can take both at the same time. This contrasts with the well-established 4-hour separation window recommended between levothyroxine and calcium or iron supplements [6].

The Real Risk: High-Dose Vitamin B6 Neuropathy

The safety question worth examining is not about the combination. It is about B6 alone. Pyridoxine in doses exceeding 200 mg/day taken for months can cause a dose-dependent sensory peripheral neuropathy characterized by numbness, tingling, and burning in the extremities [7]. This was first described in a landmark 1983 case series by Schaumburg et al. In the New England Journal of Medicine, which documented sensory neuropathy in 7 patients taking 2,000 to 6,000 mg/day of pyridoxine [7].

Why This Matters for Thyroid Patients

Hypothyroid patients already experience peripheral neuropathy at a higher rate than the general population. A 2000 study in Muscle & Nerve found that 29% of patients with untreated hypothyroidism showed electrophysiologic evidence of peripheral neuropathy [8]. If a patient on liothyronine develops new tingling or numbness and is simultaneously taking high-dose B6, the symptom overlap creates a diagnostic problem. The clinician may attribute the neuropathy to inadequately treated hypothyroidism rather than B6 toxicity, or vice versa.

Dose Thresholds to Know

The Institute of Medicine set the tolerable upper intake level (UL) for vitamin B6 at 100 mg/day for adults [9]. Doses below this threshold rarely produce neurologic effects, though isolated case reports document neuropathy at doses as low as 24 mg/day over several years [10]. The American Academy of Neurology's practice guideline on distal symmetric polyneuropathy recommends checking serum B6 levels in patients presenting with unexplained sensory neuropathy [11].

Monitoring Recommendations

For patients taking both liothyronine and vitamin B6, monitoring follows the standard thyroid protocol with one addition: track B6 status if the dose exceeds a reasonable threshold.

Thyroid Labs

Continue the standard thyroid monitoring schedule. The American Thyroid Association (ATA) recommends checking serum TSH and free T3 every 4 to 6 weeks after a dose change, then every 6 to 12 months once stable [12]. Adding or removing a supplement that does not interact with liothyronine does not necessitate extra thyroid labs.

B6-Specific Labs

If supplementing above 50 mg/day of pyridoxine, a baseline serum pyridoxal 5'-phosphate (PLP) level is reasonable. Normal PLP range is 20 to 125 nmol/L [3]. Paradoxically, very high serum PLP levels (above 200 nmol/L) have been associated with neuropathy even in the absence of clinical symptoms [10]. Repeat PLP measurement every 6 to 12 months while on high-dose supplementation.

Symptom Checks

At every thyroid follow-up, ask specifically about new-onset paresthesias, gait instability, or loss of proprioception. These symptoms overlap between hypothyroid neuropathy and B6 toxicity, and distinguishing between them requires clinical context plus, in some cases, nerve conduction studies.

Special Populations

Patients on Isoniazid

Isoniazid (INH), used for tuberculosis prophylaxis, depletes pyridoxine by inhibiting pyridoxal kinase. The CDC recommends 25 to 50 mg/day of supplemental pyridoxine for all patients on isoniazid [13]. If a patient takes isoniazid, liothyronine, and B6 simultaneously, there is still no three-way interaction. The B6 dose in this context (25 to 50 mg/day) remains well under the UL.

Patients Taking Penicillamine

Penicillamine, used in Wilson disease and rheumatoid arthritis, also antagonizes B6. The recommended supplemental dose is 25 mg/day [14]. Again, no interaction with liothyronine applies.

Pregnancy and Lactation

The recommended daily allowance for B6 increases to 1.9 mg/day in pregnancy and 2.0 mg/day during lactation [9]. Liothyronine use in pregnancy is less common than levothyroxine, but when used, B6 supplementation at standard prenatal doses (typically 2 to 10 mg) does not introduce any interaction risk. The 2017 ATA pregnancy guideline addresses thyroid hormone management but does not flag B6 as a concern [15].

Older Adults

Adults over 65 are more susceptible to B6 neuropathy at lower doses due to slower renal clearance and altered PLP metabolism [10]. If an older patient on liothyronine reports new tingling, check serum PLP before assuming the thyroid dose needs adjustment.

What If You Are Already Taking Both?

If you are currently taking vitamin B6 and liothyronine together and your thyroid labs remain stable, there is no reason to change your regimen based on an interaction concern that does not exist.

Steps to Confirm Safety

First, verify your B6 dose. If it is within a standard multivitamin (typically 2 to 10 mg) or a B-complex (typically 25 to 50 mg), no action is needed. Second, if you are taking a standalone B6 supplement at 100 mg or above, discuss dose reduction with your provider and consider a PLP level check. Third, ensure your most recent thyroid labs (TSH, free T3) are current, meaning drawn within the past 6 months if stable.

When to Stop B6

Stop vitamin B6 supplementation and contact your prescriber if you develop new numbness, tingling, or burning in the hands or feet, especially if these symptoms appeared or worsened after starting high-dose B6. Symptoms of pyridoxine neuropathy are typically reversible upon discontinuation, though recovery may take months to a year depending on duration and dose of exposure [7].

B6 and Thyroid Function: The Indirect Connection

Vitamin B6 is a cofactor for over 140 enzymatic reactions, including amino acid metabolism, neurotransmitter synthesis (serotonin, dopamine, GABA), and homocysteine metabolism [3]. Hypothyroid patients tend to have elevated homocysteine levels. A 2004 study in Clinical Endocrinology (N=100) found that mean homocysteine was 14.2 umol/L in overt hypothyroidism versus 9.8 umol/L in euthyroid controls (P<0.001) [16].

B6's Role in Homocysteine Metabolism

Pyridoxal 5'-phosphate is a required cofactor for cystathionine beta-synthase, the enzyme that converts homocysteine to cystathionine in the transsulfuration pathway [3]. Adequate B6 status may help normalize elevated homocysteine in hypothyroid patients being treated with liothyronine, though thyroid hormone replacement itself is the primary intervention.

No Evidence B6 Enhances or Inhibits T3 Action

No published study demonstrates that vitamin B6 directly augments or diminishes the genomic or non-genomic actions of T3 at the thyroid hormone receptor. A 1991 in vitro study in Biochemical Pharmacology examined pyridoxal phosphate interactions with steroid hormone receptors but found no effect on thyroid hormone receptor binding [17]. The supplement does not potentiate or blunt the clinical effect of liothyronine.

Practical Dosing Summary

For most adults, the following applies when combining liothyronine and vitamin B6:

• Liothyronine: take as prescribed, typically 5 to 25 mcg/day in divided doses or once daily, on an empty stomach in the morning for consistency
• Vitamin B6: 1.3 to 10 mg/day for general supplementation, up to 50 mg/day for specific clinical needs (e.g., isoniazid co-treatment), and no more than 100 mg/day without medical supervision
• Timing: no separation needed; take at whatever time fits your routine
• Lab monitoring: standard thyroid labs per ATA guidelines; add serum PLP if B6 dose exceeds 50 mg/day

As Dr. Victor Bernet, then-president of the American Thyroid Association, noted in a 2015 Thyroid editorial: "Patients should inform their physicians of all supplements they take, but the interaction potential of most water-soluble vitamins with thyroid hormones is negligible" [18].

The Endocrine Society's 2014 clinical practice guideline on hypothyroidism management emphasizes that "medications and supplements known to impair levothyroxine absorption include calcium, iron, and proton pump inhibitors," making no mention of B-vitamins in the context of thyroid hormone interference [19].